| Resource | ValGenesis 2.0 -- Press Release | jdum |
| Resource | Eudralex V10 Ch IV Annex III: Guidelines for the Conduct of GCP Inspections - Computerised Systems | dbartel |
| Resource | Eudralex V10 Ch IV: Guidelines for the Conduct of GCP Inspections | dbartel |
| Resource | Golzar MD, 5/08 | dbartel |
| Resource | Oncology Tech, 6/08 | dbartel |
| Resource | Encore Medical, 6/08 | dbartel |
| Resource | Rossmax International, 05/08 | dbartel |
| Resource | Merck and Company, 4/08 | dbartel |
| Resource | Stryker Biotech, 4/08 | dbartel |
| Resource | National Biological Corporation, 4/08 | dbartel |
| Resource | Heartsine Technologies, 4/08 | dbartel |
| Resource | Meeting Minutes | dbartel |
| Resource | SOP Change Control | dbartel |
| Resource | ICH Q9: Quality Risk Management | dbartel |
| Resource | Xoran Technologies, 03/08 | dbartel |
| Resource | SOP System Risk-Based Validation Approach | dbartel |
| Resource | SOP System Risk Assessment | dbartel |
| Resource | SOP System Risk Management | dbartel |
| Resource | Eudralex V4 Annex 11: GMP Guidelines for Computerised Systems (new draft) | dbartel |
| Resource | Eudralex V4 Ch 4: GMP Guidelines for Documentation (new draft) | dbartel |
| Resource | PE 010-2 PIC/S Guide to Good Practices for the Preparation of Medicinal Products in Healthcare Establishments | dbartel |
| Resource | MedX, 02/08 | dbartel |
| Resource | iScreen, 10/07 | dbartel |
| Resource | SOP Template (blank) | dbartel |
| Resource | SOP Incident Management | dbartel |
